Fertility Outcomes
Cross-source consensus on Fertility Outcomes from 1 sources and 5 claims.
1 sources · 5 claims
Comparisons
Other
Other
Other
Highlighted claims
- The primary outcome is cumulative pregnancy rate at 24 months after endometrioma treatment. — ATOPE study protocol: a randomised controlled trial comparing cystectomy and plasma vapourisation in endometriomas under 6 cm, with an observational arm for sclerotherapy in larger cysts
- Pregnancy in the study is defined by β-hCG over 1000 IU or ongoing intrauterine pregnancy confirmed by ultrasound after 5 weeks' gestational age. — ATOPE study protocol: a randomised controlled trial comparing cystectomy and plasma vapourisation in endometriomas under 6 cm, with an observational arm for sclerotherapy in larger cysts
- Secondary fertility outcomes include live birth rate, spontaneous pregnancy rate, ART pregnancy rate, and ongoing pregnancies beyond 12 weeks. — ATOPE study protocol: a randomised controlled trial comparing cystectomy and plasma vapourisation in endometriomas under 6 cm, with an observational arm for sclerotherapy in larger cysts
- The RCT power analysis assumes a 50% pregnancy rate for cystectomy and 65% for plasma vapourisation. — ATOPE study protocol: a randomised controlled trial comparing cystectomy and plasma vapourisation in endometriomas under 6 cm, with an observational arm for sclerotherapy in larger cysts
- Prior prospective case-control data found no statistically significant effect of surgical technique on pregnancy probability between cystectomy and plasma vapourisation. — ATOPE study protocol: a randomised controlled trial comparing cystectomy and plasma vapourisation in endometriomas under 6 cm, with an observational arm for sclerotherapy in larger cysts